Identification and characterization of OSTL (RNF217) encoding a RING-IBR-RING protein adjacent to a translocation breakpoint involving ETV6 in childhood ALL.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Adaptor Proteins, Signal Transducing/*genetics ; Carrier Proteins/*genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/*genetics ; Proto-Oncogene Proteins c-ets/*genetics ; Repressor Proteins/*genetics ; Translocation, Genetic/*genetics; Amino Acid Sequence ; Apoptosis/genetics ; B-Lymphocytes/cytology ; Cell Line, Tumor ; Cell Transformation, Neoplastic/genetics ; Chromosome Aberrations ; CpG Islands/genetics ; Humans ; Male ; Molecular Sequence Data ; Muscle, Skeletal/metabolism ; Protein Isoforms/genetics ; Protein Structure, Tertiary ; RNA, Long Noncoding/genetics ; Recombinant Fusion Proteins/genetics ; Sequence Alignment ; Testis/metabolism ; ETS Translocation Variant 6 Protein

Genomic aberrations involving ETV6 on band 12p13 are amongst the most common chromosomal abnormalities in human leukemia. The translocation t(6;12)(q23;13) in a childhood B-cell acute lymphoblastic leukemia (ALL) cell line fuses ETV6 with the putative long non-coding RNA gene STL. Linking STL properties to leukemia has so far been difficult. Here, we describe a novel gene, OSTL (annotated as RNF217 in Genbank), which shares the first exon and a CpG island with STL but is transcribed in the opposite direction. Human RNF217 codes for a highly conserved RING finger protein and is mainly expressed in testis and skeletal muscle with different splice variants. RNF217 shows regulated splicing in B cell development, and is expressed in a number of human B cell leukemia cell lines, primary human chronic myeloid leukemia, acute myeloid leukemia with normal karyotype and acute T-ALL samples. Using a yeast two-hybrid screen, we identified the anti-apoptotic protein HAX1 to interact with RNF217. This interaction could be mapped to the C-terminal RING finger motif of RNF217. We propose that some of the recurring aberrations involving 6q might deregulate the expression of RNF217 and result in imbalanced apoptosis signalling via HAX1, promoting leukemia development.

Cancer Cell. 2013 Mar 18;23(3):362-75. (PMID: 23518350)
Blood. 1990 Oct 15;76(8):1626-30. (PMID: 2207332)
J Cell Biol. 2014 Jan 6;204(1):61-75. (PMID: 24395636)
Recent Pat Anticancer Drug Discov. 2011 Sep;6(3):354-66. (PMID: 21635222)
Blood. 2014 Mar 13;123(11):1681-90. (PMID: 24037725)
Leuk Res. 2012 Aug;36(8):945-61. (PMID: 22578774)
J Immunol. 2009 Jun 15;182(12):7738-48. (PMID: 19494298)
Haematologica. 2008 Jan;93(1):57-66. (PMID: 18166786)
Nat Med. 2012 Oct;18(10):1550-9. (PMID: 23001182)
Cell. 2007 Feb 23;128(4):777-86. (PMID: 17320513)
Nature. 2008 Mar 6;452(7183):98-102. (PMID: 18288109)
Semin Hematol. 1999 Oct;36(4 Suppl 7):59-72. (PMID: 10595755)
Science. 2008 Dec 12;322(5908):1717-20. (PMID: 18988810)
Cancer Res. 2003 Apr 15;63(8):1900-5. (PMID: 12702581)
Curr Opin Endocrinol Diabetes Obes. 2014 Feb;21(1):30-8. (PMID: 24322424)
J Biol Chem. 2010 Jul 16;285(29):22461-72. (PMID: 20388708)
Leukemia. 2012 May;26(5):1012-9. (PMID: 22064352)
Dig Dis Sci. 2012 Jul;57(7):1838-46. (PMID: 22451114)
Mol Cells. 2008 Feb 29;25(1):86-90. (PMID: 18319618)
Nature. 1994 Nov 10;372(6502):143-9. (PMID: 7969446)
Blood. 2009 Jul 16;114(3):651-8. (PMID: 19443658)
Blood. 1994 Nov 15;84(10):3473-82. (PMID: 7949101)
J Immunol. 1997 Mar 15;158(6):2736-44. (PMID: 9058808)
Nat Genet. 2007 Jan;39(1):86-92. (PMID: 17187068)
Genes Chromosomes Cancer. 1997 Apr;18(4):254-68. (PMID: 9087565)
Leukemia. 1997 Jan;11(1):64-72. (PMID: 9001420)
Leukemia. 2011 May;25(5):868-72. (PMID: 21274001)
Nat Genet. 2000 May;25(1):19-21. (PMID: 10802648)
Blood. 2002 Mar 1;99(5):1776-84. (PMID: 11861295)
Cell. 1994 Apr 22;77(2):307-16. (PMID: 8168137)
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15751-6. (PMID: 21896721)
J Biol Chem. 2004 Nov 26;279(48):50295-301. (PMID: 15371414)
J Biol Chem. 2010 Oct 8;285(41):31616-33. (PMID: 20682791)
Oncogene. 2008 May 1;27(20):2886-96. (PMID: 18037964)
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):817-22. (PMID: 14718672)
Br J Haematol. 1994 Feb;86(2):275-83. (PMID: 8199015)
Semin Cancer Biol. 2005 Jun;15(3):162-74. (PMID: 15826831)
BMC Cell Biol. 2012 Jul 24;13:20. (PMID: 22827267)
Semin Hematol. 1990 Apr;27(2):122-36. (PMID: 2190318)
Oncogene. 2013 Aug 15;32(33):3819-28. (PMID: 22945642)
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11994-9. (PMID: 23818607)
Eur J Immunol. 2010 Nov;40(11):3161-72. (PMID: 20865787)
Leukemia. 1993 Nov;7(11):1865-74. (PMID: 8231254)
Blood. 2010 Mar 18;115(11):2251-9. (PMID: 20075161)
FEBS Lett. 2010 Jun 18;584(12):2662-9. (PMID: 20388510)
Cancer Res. 1997 Feb 15;57(4):564-9. (PMID: 9044825)
J Clin Invest. 2003 Dec;112(11):1751-61. (PMID: 14660751)
Trends Biochem Sci. 2012 Feb;37(2):58-65. (PMID: 22154517)
Nat Rev Genet. 2013 Dec;14(12):880-93. (PMID: 24217315)
Biochem Biophys Res Commun. 2010 Mar 19;393(4):794-9. (PMID: 20171186)
Nat Struct Mol Biol. 2012 Nov;19(11):1068-75. (PMID: 23132386)
Expert Rev Anticancer Ther. 2013 Mar;13(3):327-37. (PMID: 23477519)
Circ Res. 2006 Aug 18;99(4):415-23. (PMID: 16857965)
Hum Genet. 2011 Aug;130(2):223-36. (PMID: 21626138)
Genes Chromosomes Cancer. 2002 Jun;34(2):175-85. (PMID: 11979551)
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3901-6. (PMID: 23412334)
Pediatr Rep. 2011 Jun 22;3 Suppl 2:e9. (PMID: 22053285)
Cytogenet Cell Genet. 2000;91(1-4):52-6. (PMID: 11173830)
Leukemia. 2008 Jan;22(1):114-23. (PMID: 17972957)

101880 United Kingdom WT_ Wellcome Trust; 18131 United Kingdom CRUK_ Cancer Research UK; R01 CA137060 United States CA NCI NIH HHS

0 (Adaptor Proteins, Signal Transducing)
0 (Carrier Proteins)
0 (HAX1 protein, human)
0 (Protein Isoforms)
0 (Proto-Oncogene Proteins c-ets)
0 (RNA, Long Noncoding)
0 (RNF217 protein, human)
0 (Recombinant Fusion Proteins)
0 (Repressor Proteins)

Date Created: 20141010 Date Completed: 20151103 Latest Revision: 20240210

20240210

PMC4190505

10.1038/srep06565

25298122